The Venture Codex

Participated · Series C · Oct 2024

Oshi Health is a virtual digestive healthcare experience company that delivers diagnosis and integrated care for chronic gastrointestinal conditions through a virtual care delivery model. Led by CEO Sam Holliday and launched in 2020, the company works with employers, health insurers, health systems, and community GI practices to scale multidisciplinary care. It is available in all 50 states to more than 40 million people as an in-network virtual GI clinic and maintains a growing roster of in-person GI practice partners. Oshi partners with employer benefit leaders such as Dayforce, Koch Inc., Mariner, the Nielsen Company, and TE Connectivity, and with payer partners to reduce costs and improve outcomes. The company plans to use new funding to add partnerships with more provider groups, grow payer coverage, serve new employer partners, and expand into Medicare populations beginning in 2025. The recent financing will support scaling access, improving the patient experience, and expanding market reach. Oshi Health offers a virtual, high-touch care delivery model that provides dietary and behavioral health interventions for digestive conditions, delivered through hybrid collaborative arrangements with GI practices. The platform emphasizes evidence-based, multidisciplinary care aligned with clinical guidelines and iterative care to improve outcomes in virtual settings. Its approach targets gaps in access to multidisciplinary support between traditional GI visits, aiming to reduce poor outcomes and avoidable emergency services. Oshi’s work is positioned against a large burden of disease—digestive issues affect one in four working-age adults in America and drive more than $135 billion in annual healthcare costs, per the article. The company is pursuing scalable partnerships with specialty gastroenterology associations and practices to expand access and implementation. Recent strategic backing from major GI associations is presented as a catalyst for broader adoption by clinics and health systems. Oshi Health delivers virtual, multidisciplinary gastroenterology care through integrated teams of board-certified gastroenterologists, registered dietitians, GI-specialized mental health clinicians, and nurse practitioners. The company collaborates with employers, health plans, health systems, and community GI practices to expand access and reduce healthcare costs. Members receive coordinated diagnosis, treatment, and reimbursed access to dietary and behavioral therapies proven to improve GI outcomes. Oshi operates a collaborative hybrid model with community GI practices to extend access to care. The company is currently available to over 20 million people as a preferred in-network virtual gastroenterology clinic for national and regional insurers and their employer customers. CEO Sam Holliday leads efforts to scale clinical services and partnerships nationwide. Oshi Health is a virtual-first, patient-centered specialty care provider focused on gastrointestinal (GI) conditions. Led by CEO Sam Holliday, the company provides diagnosis and multidisciplinary treatment through redesigned virtual care pathways. Its evidence-based, whole-person protocols include often-neglected dietary and psychosocial interventions alongside medical care. Oshi works with employers and health insurance partners to offer its services as a covered benefit, aiming to expand access and reduce overall healthcare cost. The company intends to use the Series A proceeds to scale its virtual-first, integrated approach to GI care delivery.

Led · Equity · Feb 2024

ISHI Health is an AI-driven virtual clinic that integrates connected devices, AI algorithms, and a specialized care team to provide expert heart failure care. Its platform analyzes patients’ biometric data from external and implanted cardiac sensors across the cardiac risk spectrum to tailor precision care. ISHI operates with provider groups in California and partners collaboratively with patients’ primary cardiologists to deliver local specialist care through a complimentary care model. The company has a collaboration with Mayo Clinic to provide precision care to heart failure and cardiometabolic patients. ISHI Health raised $4M in funding and intends to use the proceeds to expand its product range and enter new markets.

Participated · Series B · Nov 2021

aptihealth is a health tech behavioral health provider. The company delivers behavioral health services supported by clinical science, technology, and services to connect patients, providers, community organizations, and health plans. aptihealth has closed a $50 million Series B funding round. Investors in the round included Takeda Digital Ventures, Pivotal Life Sciences, Vista Credit Partners, Olive Tree Ventures, Claritas Capital, and What If Ventures. The company plans to use the fresh capital to expand investment in clinical science, technology, and services to make it easy, effective, and efficient for stakeholders to work together securely.

Participated · Series A · May 2021

Seqster builds a multi-dimensional healthcare data platform that gives patients and enterprises real-time access to secure, longitudinal, and comprehensive health data. Its proprietary technology aggregates electronic health records, pharmacy, lab, genomic (DNA), fitness wearable, and social determinants of health data at the patient level and at scale. The company was founded in 2016 by Ardy Arianpour, Dr. Xiang Li, and Dana Hosseini to address fragmented data silos across healthcare. Leading biopharmaceutical companies have used Seqster for remote clinical trials and automated data collection, a capability the company says is especially critical during the COVID-19 pandemic. Seqster recently raised $12M in a Series A to grow and evolve its technology to meet demand. Management and investors expect the capital to enable further expansion into healthcare and broader deployment of its platform.

Participated · Series B · Jan 2021

Aspen RxHealth operates a clinical pharmacy services marketplace that intelligently matches pharmacists with patients using social and clinical factors. The company says its community includes more than 5,000 pharmacists, which it describes as the largest in the nation. Aspen positions its model to deliver value to health plans and other risk-bearing providers and to enrich the patient–pharmacist experience. Management plans to scale the marketplace rapidly, pursue broader markets such as specialty pharmacy support and medication reconciliation, and capitalize on increased demand for virtual care. The company framed the offering as a new clinical pharmacy services model developed by pharmacists for pharmacists and led by CEO David Medvedeff. Aspen RxHealth is a Tampa, FL–based developer of an app-based intervention platform that connects pharmacists with patients to deliver clinical services, including medication therapy management (MTM). Its offering includes a mobile app and a full technology platform that ensure quality assurance through pharmacist on-boarding and oversight of all patient interactions. The company intends to use the new funding to accelerate development of its technology platform and to add talent. Aspen RxHealth is led by CEO David Medvedeff. The article does not disclose revenues, users, or other operating metrics. The company focuses on improving clinical service delivery via pharmacist-led interventions through its technology.